The Columbia community gathered in the Hudson Valley for the eighth annual Velocity: Columbia’s Ride to End Cancer. This year’s event raised more than $1 million and attracted nearly 600 participants.
Columbia researchers have engineered bacteria as personalized cancer vaccines that activate the immune system to specifically seek out and destroy cancer cells.
Physician-scientist Juanma Schvartzman is a firm believer that his curiosity-driven research on cell metabolism and its influence on cell identity will offer clues for better cancer treatments.
The latest advance in radiation therapy—using AI to adjust treatments as needed—is now available for select cancer patients at Columbia University Irving Medical Center/NewYork-Presbyterian.
The rate of cervical cancer among women living in neighborhoods with the lowest socioeconomic indices is nearly two times higher than the rate among those who live in areas with the highest indices.
A Columbia study may lead to stomach cancer screening guidelines, especially for Black and Hispanic Americans who have a greater risk of developing or dying from stomach cancer than white Americans.
Columbia University's chief of breast imaging, Elise Desperito, MD, clarifies conflicting advice on mammography and urges all women to be evaluated for their breast cancer risk.
Columbia breast cancer patient Karin Diamond credits regular mammograms for catching her cancer early and her surgeon's use of intraoperative radiation for keeping her cancer-free.
Overall survival for breast cancer has improved by about 40% since the 1980s. Precision medicine and new screening tests may lead to even better outcomes in the future.
The 2021 edition of Velocity raised $1.1 million to support cancer research and care at Columbia University's Herbert Irving Comprehensive Cancer Center.